Third Harmonic Bio, Inc. (THRD) Financials

THRD Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 282.3 million 9.3 million
2023-06-30 285.8 million 7.8 million
2023-03-31 291.4 million 8.7 million
2022-12-31 298.7 million 9.6 million

THRD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -4.2 million 2.3 million
2023-06-30 -4.1 million 2.8 million
2023-03-31 -6.7 million 2.7 million
2022-12-31 -9.3 million 2.1 million

THRD Net Income

No data available :(

THRD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 273.9 million - 4.1 million
2023-06-30 278.1 million - 4.3 million
2023-03-31 282.2 million - 4.4 million
2022-12-31 288.9 million - 4.3 million

THRD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 39.7 million
2023-06-30 39.6 million
2023-03-31 22.8 million
2022-12-31 13.4 million

THRD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 6.0 million 4.9 million -
2023-06-30 168000 5.3 million 5.4 million -
2023-03-31 168000 6.7 million 5.3 million -
2022-12-31 36000 9.3 million 4.3 million -

THRD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 178000
2023-06-30 - 168000
2023-03-31 - 72000
2022-12-31 - 38000

THRD

Price: $11.70

52 week price:
4.06
12.42

Earnings Per Share: -0.78 USD

P/E Ratio: 12.71

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 101800

Market Capitalization: 487.8 million

Links: